ZYNERBA PHARMACEUTICALS INC's ticker is ZYNE and the CUSIP is 98986X109. A total of 60 filers reported holding ZYNERBA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $310,955 | -61.2% | 723,151 | -52.1% | 0.01% | -73.7% |
| Q4 2022 | $800,762 | -51.6% | 1,510,872 | -33.1% | 0.04% | -28.3% |
| Q3 2022 | $1,654,000 | -41.2% | 2,258,970 | -7.7% | 0.05% | -34.6% |
| Q2 2022 | $2,815,000 | -64.2% | 2,447,407 | -33.2% | 0.08% | -48.7% |
| Q1 2022 | $7,874,000 | -41.0% | 3,662,342 | -20.1% | 0.16% | -40.2% |
| Q4 2021 | $13,345,000 | -28.8% | 4,585,741 | +2.7% | 0.26% | -25.2% |
| Q3 2021 | $18,748,000 | -24.5% | 4,463,774 | -2.5% | 0.35% | -12.8% |
| Q2 2021 | $24,820,000 | +168.5% | 4,579,280 | +130.4% | 0.40% | +147.0% |
| Q1 2021 | $9,243,000 | +54.4% | 1,987,786 | +9.6% | 0.16% | +25.2% |
| Q4 2020 | $5,987,000 | +103.0% | 1,814,328 | +103.6% | 0.13% | +39.4% |
| Q3 2020 | $2,949,000 | -29.5% | 891,025 | -28.2% | 0.09% | -36.5% |
| Q2 2020 | $4,184,000 | -9.6% | 1,241,596 | +2.8% | 0.15% | -31.2% |
| Q1 2020 | $4,627,000 | -62.4% | 1,208,126 | -40.7% | 0.22% | -49.8% |
| Q4 2019 | $12,301,000 | -39.3% | 2,036,530 | -24.0% | 0.43% | -41.3% |
| Q3 2019 | $20,257,000 | -33.2% | 2,679,457 | +19.7% | 0.73% | -24.5% |
| Q2 2019 | $30,323,000 | – | 2,237,843 | – | 0.96% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 507,191 | $5,107,000 | 0.50% |
| Cormorant Asset Management, LP | 356,600 | $3,591,000 | 0.43% |
| Perceptive Advisors | 558,446 | $5,623,000 | 0.42% |
| NEXTHERA CAPITAL LP | 15,000 | $151,000 | 0.21% |
| EMERALD ADVISERS, LLC | 237,070 | $2,387,000 | 0.11% |
| AUXIER ASSET MANAGEMENT | 17,857 | $180,000 | 0.04% |
| FEDERATED HERMES, INC. | 450,000 | $4,532,000 | 0.01% |
| Nationwide Fund Advisors | 49,473 | $498,000 | 0.00% |
| Catalyst Capital Advisors LLC | 348 | $4,000 | 0.00% |
| DEUTSCHE BANK AG\ | 859 | $8,000 | 0.00% |